Developer docs
API playgroundTry for free, no card

Search company profiles

Acutaas Chemicals

Full company profile

uuid0002fcb

Namestring
Acutaas Chemicals
Legal namestring
Acutaas Chemicals Limited
Websiteurl
amiorganics.com
Company typeenum
Public
Founded yearint
2004
Descriptiontext

Acutaas Chemicals Limited (formerly Ami Organics, founded 2004) is an Indian specialty chemicals manufacturer headquartered in Sachin, Gujarat, and listed on the BSE and NSE under the ticker AMIORG. The company operates five manufacturing facilities — four in India (Sachin, Ankleshwar, Jhagadia, and Greater Noida) and one in Gong-Ju, South Korea — with a combined capacity of 1,100 KL and a portfolio of 610+ active products. Acutaas is the only domestic Indian manufacturer of semiconductor-grade photoresist chemicals and the first company in India (outside China) to develop battery electrolyte additives at commercial scale.

The company's product portfolio spans four lines: Advanced Pharmaceutical Intermediates (serving 160+ customers across 25+ countries through USFDA- and PMDA-approved facilities), Semiconductor Chemicals (exported to the US, Korea, Japan, and Taiwan), Battery Chemicals (electrolyte additives for EV and energy storage), and Commodity Chemicals (30+ products for personal care, agriculture, coatings, and fine chemicals). Underlying capabilities include Flow Chemistry, Green Chemistry, Chiral Chemistry, and Analytical Development, supported by a 130+ member R&D team and multiple international certifications (USFDA, PMDA, ISO 9001/14001/45001/27001, SA 8000, Kosher, Halal, SGS GMP, 21 CFR Part 11). The company rebranded from Ami Organics to Acutaas Chemicals in May 2025 to signal a broader global identity focused on precision chemistry.

Acutaas operates a direct B2B enterprise sales motion, monetizing through CDMO and CMO service contracts, custom synthesis, process development, and direct specialty chemical sales. Pricing is quote-based and negotiated with multi-year contracts, with revenue streams covering professional services (CDMO/CMO), specialty chemical transactions, and technology-transfer licensing. For FY26 (ended March 2026), the company reported Rs 1,339.37 crore in consolidated revenue (up 33.02% YoY) and Rs 356.26 crore in net profit (up 124.47% YoY), serving 600+ customers across 55+ countries.

Short descriptiontext

Acutaas Chemicals is an Indian specialty chemicals manufacturer producing pharmaceutical intermediates, semiconductor photoresist chemicals, battery electrolyte additives, and commodity chemicals across five facilities. It serves 600+ global customers in 55+ countries through CDMO/CMO services and direct B2B sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSachin, India
HQ citystring
Sachin
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty chemicals, pharmaceutical intermediates, semiconductor chemicals, battery chemicals, custom synthesis services
Industry3 codes
1Electronic & High-Purity Specialty Chemicals
CodeIMAEABADPrimaryYes
2Deposition Precursors (CVD/ALD Precursors, Metalorganics)
CodeIMAEAKAGPrimaryNo
3Contract Development & Manufacturing for Generics (CDMO/CMO)
CodeHLAIABAIPrimaryNo
NAICS code3 codes
  • Chemical Manufacturing325
  • All Other Chemical Product and Preparation Manufacturing32599
  • Other Basic Organic Chemical Manufacturing32519
SIC code2 codes
  • Miscellaneous Chemical Products2890
  • Chemicals & Allied Products2800
Product category
Specialty Chemicals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1CDMO Services
TypeProfessional Services
Description

Contract Development and Manufacturing Organization services providing integrated development support from first route selection to market-ready manufacturing stages. Includes custom synthesis and process development.

acutaas.com
2CMO Services
TypeOne Time License
Description

Commercial scale production with robust tech transfer and industry-aligned compliance systems for pharmaceutical intermediates and specialty chemicals.

acutaas.com
3Specialty Chemicals Sales
TypeTransaction Fee
Description

Sale of Advanced Pharmaceutical Intermediates, Semiconductor Chemicals, Battery Chemicals, and Commodity Chemicals to global customers.

acutaas.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Custom quotation-based pricing for CDMO/CMO services and specialty chemical products
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is negotiated directly with customers based on product specifications, volumes, and contract terms. No public pricing tiers available.

acutaas.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Acutaas Chemicals (formerly Ami Organics) is a specialty chemicals manufacturer that produces pharmaceutical intermediates, semiconductor chemicals, battery chemicals, and commodity chemicals from five manufacturing facilities in India and South Korea. The company also offers CDMO, CMO, custom synthesis, and process development services with USFDA and PMDA certifications, serving 600+ customers across 55+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 43% YoY revenue growth to Rs 393 crore in Q3FY26
+5 more records
Product overview1 text field

Acutaas Chemicals Limited is a specialty chemicals company offering a portfolio of four core product lines: Advanced Pharmaceutical Intermediates (serving 160+ customers with USFDA/PMDA-approved facilities), Semiconductor Chemicals (India's only manufacturer of semiconductor-grade photoresist chemicals), Battery Chemicals (first in India outside China to develop electrolyte additives commercially), and Commodity Chemicals (30+ products for personal care, agriculture, coatings, and fine chemicals). The company complements its products with four service offerings: CDMO (integrated development from route selection to market), CMO (commercial-scale manufacturing), Custom Synthesis (complex chemistry programs), and Process Development (route design and scale-up). Five manufacturing facilities are located across Gujarat (India) and South Korea.

Product and service8 records
1Pharmaceutical Intermediates
CategoryPharmaceutical Chemicals
Description

Specialty chemical intermediates supplied to global pharmaceutical companies for use in active pharmaceutical ingredient (API) manufacturing, produced at USFDA and PMDA certified facilities.

2Semiconductor Chemicals
CategorySpecialty Chemicals
Description

High-purity specialty chemicals supplied to semiconductor and electronics manufacturers for wafer processing and fabrication applications.

3Battery Chemicals
CategorySpecialty Chemicals
Description

Specialty chemicals supplied to lithium-ion battery and EV material manufacturers for use in battery cell and material production.

4Commodity Chemicals
CategoryCommodity Chemicals
Description

Bulk commodity chemicals supplied primarily to industrial customers across the company's global footprint.

5CDMO Services
CategoryContract Manufacturing Services
Description

Contract development and manufacturing services for pharmaceutical and specialty chemical clients, leveraging the company's certified manufacturing facilities.

6CMO Services
CategoryContract Manufacturing Services
Description

Contract manufacturing services for pharmaceutical and specialty chemical clients, utilizing the company's manufacturing infrastructure in India and South Korea.

7Custom Synthesis Services
CategoryCustom Synthesis Services
Description

Bespoke chemical synthesis services tailored to specific customer requirements for pharmaceutical and specialty chemical applications.

8Process Development Services
CategoryProcess Development Services
Description

Process research, development, and scale-up services for chemical manufacturing, supporting client product development and commercialization.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-01
Description

A forward-looking partnership signed in June 2025 to set up capabilities in South Korea for material innovation and next-gen chemistries. This partnership established Unit-V facility in Gong-Ju, South Korea for developing advanced chemical materials.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

India-headquartered pharmaceutical CDMO offering custom synthesis of APIs and intermediates to global pharma, with USFDA/EMA-approved facilities. Highly comparable to Acutaas's pharma intermediates and CDMO model, though larger and more API-focused.

TypeDirect peer
Description

Indian pharmaceutical CDMO specializing in complex intermediates, peptides, and APIs for global pharma. Direct comparable on pharma intermediates, custom synthesis, and small-molecule CDMO services with regulatory-approved manufacturing.

TypeDirect peer
Description

Indian specialty chemicals and CDMO company serving pharmaceuticals and agrochemicals, with custom synthesis and contract manufacturing. Closely aligned with Acutaas across pharma intermediates, agrochemical intermediates, and contract manufacturing services.

TypeDirect peer
Description

Indian specialty chemicals company focused on fluorination, custom synthesis, and pharmaceutical intermediates. Comparable on specialty chemicals manufacturing, CDMO services, and pharma intermediates focus.

TypeDirect peer
Description

Indian pharmaceutical and CDMO player with strong intermediates and API franchises serving global generics and specialty pharma. Comparable on pharma CDMO, intermediates, and large-scale manufacturing for export markets.

TypeBroad incumbent
Description

Diversified Indian specialty chemicals major with pharma intermediates, fluorochemicals, packaging films, and technical textiles. Overlaps with Acutaas on specialty chemicals manufacturing and pharma intermediates, though significantly larger and broader.

TypeBroad incumbent
Description

Indian pharma CDMO with radiopharma, allergy therapeutics, and contract research/manufacturing operations. Overlaps with Acutaas on pharma CDMO and intermediates, with broader radiopharma and CRAMS exposure.

TypeDirect peer
Description

Japanese specialty chemical manufacturer and global leader in photoresist chemicals for semiconductor and display manufacturing. Highly directly comparable to Acutaas's photoresist chemicals business, though at meaningfully larger global scale.

TypeBroad incumbent
Description

Global specialty chemicals and semiconductor materials leader with major share in photoresists, silicon wafers, and rare earth magnets. Comparable on semiconductor-grade specialty chemicals leadership, though a much larger diversified chemicals incumbent.

TypeRegional player
Description

Indian specialty chemicals manufacturer focused on intermediates including ATBS, isobutylene derivatives, and pharma intermediates. Comparable on Indian specialty chemicals manufacturing, custom intermediates, and B2B export model, though product mix differs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Acutaas Chemicals

Specialty Chemicalsamiorganics.com

Acutaas Chemicals is an Indian specialty chemicals manufacturer producing pharmaceutical intermediates, semiconductor photoresist chemicals, battery electrolyte additives, and commodity chemicals across five facilities. It serves 600+ global customers in 55+ countries through CDMO/CMO services and direct B2B sales.

What Acutaas Chemicals does

Acutaas Chemicals Limited (formerly Ami Organics, founded 2004) is an Indian specialty chemicals manufacturer headquartered in Sachin, Gujarat, and listed on the BSE and NSE under the ticker AMIORG. The company operates five manufacturing facilities — four in India (Sachin, Ankleshwar, Jhagadia, and Greater Noida) and one in Gong-Ju, South Korea — with a combined capacity of 1,100 KL and a portfolio of 610+ active products. Acutaas is the only domestic Indian manufacturer of semiconductor-grade photoresist chemicals and the first company in India (outside China) to develop battery electrolyte additives at commercial scale.

The company's product portfolio spans four lines: Advanced Pharmaceutical Intermediates (serving 160+ customers across 25+ countries through USFDA- and PMDA-approved facilities), Semiconductor Chemicals (exported to the US, Korea, Japan, and Taiwan), Battery Chemicals (electrolyte additives for EV and energy storage), and Commodity Chemicals (30+ products for personal care, agriculture, coatings, and fine chemicals). Underlying capabilities include Flow Chemistry, Green Chemistry, Chiral Chemistry, and Analytical Development, supported by a 130+ member R&D team and multiple international certifications (USFDA, PMDA, ISO 9001/14001/45001/27001, SA 8000, Kosher, Halal, SGS GMP, 21 CFR Part 11). The company rebranded from Ami Organics to Acutaas Chemicals in May 2025 to signal a broader global identity focused on precision chemistry.

Acutaas operates a direct B2B enterprise sales motion, monetizing through CDMO and CMO service contracts, custom synthesis, process development, and direct specialty chemical sales. Pricing is quote-based and negotiated with multi-year contracts, with revenue streams covering professional services (CDMO/CMO), specialty chemical transactions, and technology-transfer licensing. For FY26 (ended March 2026), the company reported Rs 1,339.37 crore in consolidated revenue (up 33.02% YoY) and Rs 356.26 crore in net profit (up 124.47% YoY), serving 600+ customers across 55+ countries.

Acutaas Chemicals firmographics

Firmographics
Name
Acutaas Chemicals
Legal name
Acutaas Chemicals Limited
Website
https://amiorganics.com
Company type
Public
Founded year
2004
Operating status
Operating
Headcount range
251–500 employees
Short description
Acutaas Chemicals is an Indian specialty chemicals manufacturer producing pharmaceutical intermediates, semiconductor photoresist chemicals, battery electrolyte additives, and commodity chemicals across five facilities. It serves 600+ global customers in 55+ countries through CDMO/CMO services and direct B2B sales.
Ownership category
akta.pro rank

Acutaas Chemicals industry classification

Industry
Product category
Specialty Chemicals
NAICS
Chemical Manufacturing (325), All Other Chemical Product and Preparation Manufacturing (32599), Other Basic Organic Chemical Manufacturing (32519)
SIC
Miscellaneous Chemical Products (2890), Chemicals & Allied Products (2800)
akta.pro primary industry
Electronic & High-Purity Specialty Chemicals (IMAEABAD)
akta.pro secondary industries
Deposition Precursors (CVD/ALD Precursors, Metalorganics) (IMAEAKAG), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

  • Specialty chemicals
  • Pharmaceutical intermediates
  • Semiconductor chemicals
  • Battery chemicals
  • Custom synthesis services

Where Acutaas Chemicals is headquartered

Location

Headquarters

HQ city
Sachin
HQ country
India
HQ region
Asia

Offices5 records

Markets served

Acutaas Chemicals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. CDMO Services: Contract Development and Manufacturing Organization services providing integrated development support from first route selection to market-ready manufacturing stages. Includes custom synthesis and process development.
  2. CMO Services: Commercial scale production with robust tech transfer and industry-aligned compliance systems for pharmaceutical intermediates and specialty chemicals.
  3. Specialty Chemicals Sales: Sale of Advanced Pharmaceutical Intermediates, Semiconductor Chemicals, Battery Chemicals, and Commodity Chemicals to global customers.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom quotation-based pricing for CDMO/CMO services and specialty chemical products

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Acutaas Chemicals product offering

Product offering

Core offering

Acutaas Chemicals (formerly Ami Organics) is a specialty chemicals manufacturer that produces pharmaceutical intermediates, semiconductor chemicals, battery chemicals, and commodity chemicals from five manufacturing facilities in India and South Korea. The company also offers CDMO, CMO, custom synthesis, and process development services with USFDA and PMDA certifications, serving 600+ customers across 55+ countries.

Product overview

Acutaas Chemicals Limited is a specialty chemicals company offering a portfolio of four core product lines: Advanced Pharmaceutical Intermediates (serving 160+ customers with USFDA/PMDA-approved facilities), Semiconductor Chemicals (India's only manufacturer of semiconductor-grade photoresist chemicals), Battery Chemicals (first in India outside China to develop electrolyte additives commercially), and Commodity Chemicals (30+ products for personal care, agriculture, coatings, and fine chemicals). The company complements its products with four service offerings: CDMO (integrated development from route selection to market), CMO (commercial-scale manufacturing), Custom Synthesis (complex chemistry programs), and Process Development (route design and scale-up). Five manufacturing facilities are located across Gujarat (India) and South Korea.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Intermediates Specialty chemical intermediates supplied to global pharmaceutical companies for use in active pharmaceutical ingredient (API) manufacturing, produced at USFDA and PMDA certified facilities.
  • Semiconductor Chemicals High-purity specialty chemicals supplied to semiconductor and electronics manufacturers for wafer processing and fabrication applications.
  • Battery Chemicals Specialty chemicals supplied to lithium-ion battery and EV material manufacturers for use in battery cell and material production.
  • Commodity Chemicals Bulk commodity chemicals supplied primarily to industrial customers across the company's global footprint.
  • CDMO Services Contract development and manufacturing services for pharmaceutical and specialty chemical clients, leveraging the company's certified manufacturing facilities.
  • CMO Services Contract manufacturing services for pharmaceutical and specialty chemical clients, utilizing the company's manufacturing infrastructure in India and South Korea.
  • Custom Synthesis Services Bespoke chemical synthesis services tailored to specific customer requirements for pharmaceutical and specialty chemical applications.
  • Process Development Services Process research, development, and scale-up services for chemical manufacturing, supporting client product development and commercialization.

Quantifiable outcome

  • 43% YoY revenue growth to Rs 393 crore in Q3FY26
  • +5 more outcomes

Companies that use Acutaas Chemicals

Customer profile

Named customers3 records

Segments7 records

Ideal customer profiles3 records

Acutaas Chemicals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Acutaas Chemicals partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • South Korean PartnercoreStrategic or Co-development Partner · 1 June 2025A forward-looking partnership signed in June 2025 to set up capabilities in South Korea for material innovation and next-gen chemistries. This partnership established Unit-V facility in Gong-Ju, South Korea for developing advanced chemical materials.

Scale indicators14 records

Recent moves7 records

Expansion highlights5 records

Acutaas Chemicals competitors and assessment

Company assessment

Direct peers

  • Divi's Laboratories: India-headquartered pharmaceutical CDMO offering custom synthesis of APIs and intermediates to global pharma, with USFDA/EMA-approved facilities. Highly comparable to Acutaas's pharma intermediates and CDMO model, though larger and more API-focused.
  • Neuland Labs: Indian pharmaceutical CDMO specializing in complex intermediates, peptides, and APIs for global pharma. Direct comparable on pharma intermediates, custom synthesis, and small-molecule CDMO services with regulatory-approved manufacturing.
  • Hikal Limited: Indian specialty chemicals and CDMO company serving pharmaceuticals and agrochemicals, with custom synthesis and contract manufacturing. Closely aligned with Acutaas across pharma intermediates, agrochemical intermediates, and contract manufacturing services.
  • Navin Fluorine International: Indian specialty chemicals company focused on fluorination, custom synthesis, and pharmaceutical intermediates. Comparable on specialty chemicals manufacturing, CDMO services, and pharma intermediates focus.
  • Laurus Labs: Indian pharmaceutical and CDMO player with strong intermediates and API franchises serving global generics and specialty pharma. Comparable on pharma CDMO, intermediates, and large-scale manufacturing for export markets.
  • Tokyo Ohka Kogyo (TOK): Japanese specialty chemical manufacturer and global leader in photoresist chemicals for semiconductor and display manufacturing. Highly directly comparable to Acutaas's photoresist chemicals business, though at meaningfully larger global scale.

Broad incumbents

  • SRF Limited: Diversified Indian specialty chemicals major with pharma intermediates, fluorochemicals, packaging films, and technical textiles. Overlaps with Acutaas on specialty chemicals manufacturing and pharma intermediates, though significantly larger and broader.
  • Jubilant Pharmova: Indian pharma CDMO with radiopharma, allergy therapeutics, and contract research/manufacturing operations. Overlaps with Acutaas on pharma CDMO and intermediates, with broader radiopharma and CRAMS exposure.
  • Shin-Etsu Chemical: Global specialty chemicals and semiconductor materials leader with major share in photoresists, silicon wafers, and rare earth magnets. Comparable on semiconductor-grade specialty chemicals leadership, though a much larger diversified chemicals incumbent.

Regional players

  • Vinati Organics: Indian specialty chemicals manufacturer focused on intermediates including ATBS, isobutylene derivatives, and pharma intermediates. Comparable on Indian specialty chemicals manufacturing, custom intermediates, and B2B export model, though product mix differs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Acutaas Chemicals social profiles

Digital presence

Acutaas Chemicals compliance and trust

Trust signal

Compliance10 records

Acutaas Chemicals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Acutaas Chemicals leadership team

Management profile

Number of profiles

Profiles1 record

Acutaas Chemicals funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Acutaas Chemicals M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Acutaas Chemicals

What does Acutaas Chemicals do?

Acutaas Chemicals (formerly Ami Organics) is a specialty chemicals manufacturer that produces pharmaceutical intermediates, semiconductor chemicals, battery chemicals, and commodity chemicals from five manufacturing facilities in India and South Korea. The company also offers CDMO, CMO, custom synthesis, and process development services with USFDA and PMDA certifications, serving 600+ customers across 55+ countries.

Is Acutaas Chemicals a public or private company?

Acutaas Chemicals is a public company. It is classified as public and is currently operating.

When was Acutaas Chemicals founded?

Acutaas Chemicals was founded in 2004. It employs 251 to 500 people.

Where is Acutaas Chemicals based?

Acutaas Chemicals is headquartered in Sachin, India, in the Asia region.

How does Acutaas Chemicals make money?

Three revenue lines are on record. CDMO Services are the primary driver. The others are CMO Services and specialty Chemicals Sales.

Who are Acutaas Chemicals's main competitors?

Direct peers on record are Divi's Laboratories, Neuland Labs, Hikal Limited, Navin Fluorine International, Laurus Labs and Tokyo Ohka Kogyo (TOK). Broad incumbents are SRF Limited, Jubilant Pharmova and Shin-Etsu Chemical. Vinati Organics is listed as a regional player.

Does Acutaas Chemicals have an API?

No public API is recorded for Acutaas Chemicals.

What industry is Acutaas Chemicals in?

Acutaas Chemicals's product category is Specialty Chemicals. Its primary akta.pro industry code is IMAEABAD, Electronic & High-Purity Specialty Chemicals, with a secondary code of IMAEAKAG, Deposition Precursors (CVD/ALD Precursors, Metalorganics). Its NAICS code is 325 and its SIC code is 2890.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MintPharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price | Stock Market NewsInCred Equities rates Acutaas Chemicals, Mankind Pharma, and Ipca Laboratories as 'Add' with target prices of ₹4757, ₹2945, and ₹2044, respectively, citing up to 49.89% upside. The brokerage expects these firms to outperform in Q2FY27, while Dr Reddy's, Divi's, Lupin, Cipla, Torrent, and Blue Jet may face pressure.NDTV ProfitDalal Street's New Chemistry: How India's Chip Push Is Fueling A Specialty Chemical RallyIndia's semiconductor push is creating demand for electronic-grade chemicals, with over 70% currently imported. Companies like Aether Industries and Acutaas Chemicals have invested heavily, with Aether gaining 136% and Acutaas 143% in stock. Valuations remain elevated, but forward valuations are lower, indicating expected earnings growth.NDTV ProfitDalal Street's New Chemistry: How India's Chip Push Is Fueling A Specialty Chemical RallyIndia's semiconductor push is creating demand for specialty chemicals, with over 70% of electronic-grade chemicals currently imported. Companies like Aether Industries and Acutaas Chemicals have invested heavily, with Aether gaining 136% and Acutaas 143% on Dalal Street. Valuations remain elevated, but forward valuations are lower, indicating expected earnings growth.NDTV ProfitIndia’s Chip Push Sparks New Opportunity For Specialty Chemical Stocks: Here's HowIndia's semiconductor push is creating a new opportunity for specialty chemical companies as the country builds fabs and advanced packaging plants. With over 70% of electronic-grade chemicals still imported, companies like Aether Industries and Acutaas Chemicals are expanding, though elevated valuations remain a key factor for investors.ScanXAcutaas Chemicals approves acquisition of step-down subsidiary Enchem Ami OrganicsAcutaas Chemicals approved acquiring 100% of its step-down subsidiary Enchem Ami Organics Private Limited, transferring shares at face value of ₹10 per share. The transaction, completed within one month, makes EAOPL a direct wholly owned subsidiary, with the target reporting nil turnover for FY25 and FY26.Business TodayStocks to BUY: Airtel, Acutaas समेत 4 शेयरों में तेजी के संकेत- ब्रोकरेज ने बताए खरीदारी के मौके और टारगेटIndian brokers recommend buying Bharti Airtel, Acutaas Chemicals, Jubilant Pharmova, and NOCIL on short-term technical signals. Targets range from 2,020 for Airtel to 3,652 for Acutaas, with stop-losses set below current levels.BusinessLineStock to buy today: Acutaas Chemicals (₹3,315.60)Acutaas Chemicals stock is trading at ₹3,315, with technical analysis suggesting a long position. The stock is expected to surpass ₹3,500 and reach ₹4,000 in the long term, with a stop-loss at ₹2,900. The recommendation is based on technical analysis, carrying a risk of loss.BusinessLineToday’s Stock Recommendation: September 18, 2026A stock recommendation for September 18, 2026 highlights Acutaas Chemicals, which hit a record high and is now consolidating. The analysis expects the stock to regain traction, break out of resistance, and make fresh highs.BusinessLineAcutaas Chemicals: Offering multi-vertical growth runwayAcutaas Chemicals has delivered nearly 6x returns since its 2021 IPO, with 31% revenue and 45% EPS CAGR over FY21-26. The company expanded into CDMO, battery, and semiconductor chemicals, raising EBITDA margins to 34% in FY26. It expects to sustain growth while maintaining margins, though valuation remains high at 55 times forward earnings.BusinessLineBroker’s call: Acutaas Chem (Buy)Acutaas Chemicals is rated Buy with a target price of ₹3,800, based on a 45x Sep'28E EPS. The firm expects 28% CAGR in CDMO revenue and 45% in specialty chemicals, with Daro volumes reaching 160 tonnes by FY30E. The note marks resumption of coverage.